DEVELOPING A RANGE OF PHARMACEUTICAL PROJECTS:
- Breezula® (Clascoterone solution)
A novel androgen receptor inhibitor that targets androgen receptors in the scalp and is currently being studied for the treatment of androgenetic alopecia (AGA) - GI Genius™
AI-enhanced endoscopy aid software - Methylene Blue MMX®
A new diagnostic drug to improve pre-cancerous and cancerous lesion detection during colonoscopies - Aemcolo® 200 mg and 600mg
A new antibiotic whose API is rifamycin SV, engineered with MMX® technology - CB-03-10 (Cortexolone 17α-valerate-21-propionate)
Oral AR antagonist against solid tumors - CB-01-33 (colesevelam)
Colesevelam formulated with Cosmo’s proprietary technology has the potential to overcome the current concerns for bile acid sequestrants for the treatment of bile acid diarrhea (BAD)